KONINKLIJKE PHILIPS NVR- NY (PHG) Stock Fundamental Analysis

USA • New York Stock Exchange • NYSE:PHG • US5004723038

29.09 USD
+0.19 (+0.66%)
Last: Feb 3, 2026, 10:54 AM
Fundamental Rating

4

Overall PHG gets a fundamental rating of 4 out of 10. We evaluated PHG against 186 industry peers in the Health Care Equipment & Supplies industry. PHG has a medium profitability rating, but doesn't score so well on its financial health evaluation. PHG has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

  • In the past year PHG was profitable.
  • PHG had a positive operating cash flow in the past year.
  • The reported net income has been mixed in the past 5 years: PHG reported negative net income in multiple years.
  • PHG had a positive operating cash flow in 4 of the past 5 years.
PHG Yearly Net Income VS EBIT VS OCF VS FCFPHG Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B

1.2 Ratios

  • PHG has a Return On Assets of 0.63%. This is in the better half of the industry: PHG outperforms 74.19% of its industry peers.
  • PHG has a Return On Equity of 1.56%. This is in the better half of the industry: PHG outperforms 75.27% of its industry peers.
  • PHG has a Return On Invested Capital of 4.44%. This is in the better half of the industry: PHG outperforms 75.27% of its industry peers.
Industry RankSector Rank
ROA 0.63%
ROE 1.56%
ROIC 4.44%
ROA(3y)-3.08%
ROA(5y)1.15%
ROE(3y)-7.29%
ROE(5y)2.23%
ROIC(3y)N/A
ROIC(5y)N/A
PHG Yearly ROA, ROE, ROICPHG Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20

1.3 Margins

  • With a decent Profit Margin value of 0.93%, PHG is doing good in the industry, outperforming 74.19% of the companies in the same industry.
  • With a decent Operating Margin value of 6.10%, PHG is doing good in the industry, outperforming 71.51% of the companies in the same industry.
  • PHG's Operating Margin has declined in the last couple of years.
  • PHG has a worse Gross Margin (43.49%) than 63.44% of its industry peers.
  • PHG's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 6.1%
PM (TTM) 0.93%
GM 43.49%
OM growth 3Y-1.59%
OM growth 5Y-8.09%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.71%
GM growth 5Y1.08%
PHG Yearly Profit, Operating, Gross MarginsPHG Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40

More info and screens

3

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so PHG is destroying value.
  • PHG has less shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, PHG has more shares outstanding
  • The debt/assets ratio for PHG is higher compared to a year ago.
PHG Yearly Shares OutstandingPHG Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M
PHG Yearly Total Debt VS Total AssetsPHG Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

2.2 Solvency

  • An Altman-Z score of 1.98 indicates that PHG is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • PHG has a better Altman-Z score (1.98) than 60.22% of its industry peers.
  • The Debt to FCF ratio of PHG is 14.51, which is on the high side as it means it would take PHG, 14.51 years of fcf income to pay off all of its debts.
  • The Debt to FCF ratio of PHG (14.51) is better than 70.97% of its industry peers.
  • PHG has a Debt/Equity ratio of 0.69. This is a neutral value indicating PHG is somewhat dependend on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 0.69, PHG is doing worse than 67.20% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.69
Debt/FCF 14.51
Altman-Z 1.98
ROIC/WACC0.65
WACC6.8%
PHG Yearly LT Debt VS Equity VS FCFPHG Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B 10B

2.3 Liquidity

  • A Current Ratio of 1.32 indicates that PHG should not have too much problems paying its short term obligations.
  • Looking at the Current ratio, with a value of 1.32, PHG is doing worse than 77.42% of the companies in the same industry.
  • PHG has a Quick Ratio of 1.32. This is a bad value and indicates that PHG is not financially healthy enough and could expect problems in meeting its short term obligations.
  • PHG's Quick ratio of 0.86 is on the low side compared to the rest of the industry. PHG is outperformed by 80.65% of its industry peers.
Industry RankSector Rank
Current Ratio 1.32
Quick Ratio 0.86
PHG Yearly Current Assets VS Current LiabilitesPHG Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B

More info and screens

4

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an nice 15.15% over the past year.
  • PHG shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -7.17% yearly.
  • The Revenue has decreased by -1.43% in the past year.
  • Measured over the past years, PHG shows a small growth in Revenue. The Revenue has been growing by 1.00% on average per year.
EPS 1Y (TTM)15.15%
EPS 3Y-5.66%
EPS 5Y-7.17%
EPS Q2Q%12.5%
Revenue 1Y (TTM)-1.43%
Revenue growth 3Y1.65%
Revenue growth 5Y1%
Sales Q2Q%-1.71%

3.2 Future

  • The Earnings Per Share is expected to grow by 10.28% on average over the next years. This is quite good.
  • Based on estimates for the next years, PHG will show a small growth in Revenue. The Revenue will grow by 3.00% on average per year.
EPS Next Y4.94%
EPS Next 2Y4.81%
EPS Next 3Y7.44%
EPS Next 5Y10.28%
Revenue Next Year-2.27%
Revenue Next 2Y0.25%
Revenue Next 3Y1.58%
Revenue Next 5Y3%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
PHG Yearly Revenue VS EstimatesPHG Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 5B 10B 15B 20B 25B
PHG Yearly EPS VS EstimatesPHG Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0.5 1 1.5 2

More info and screens

5

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 16.62, which indicates a correct valuation of PHG.
  • Compared to the rest of the industry, the Price/Earnings ratio of PHG indicates a rather cheap valuation: PHG is cheaper than 88.17% of the companies listed in the same industry.
  • PHG is valuated rather cheaply when we compare the Price/Earnings ratio to 28.41, which is the current average of the S&P500 Index.
  • The Price/Forward Earnings ratio is 16.15, which indicates a correct valuation of PHG.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of PHG indicates a rather cheap valuation: PHG is cheaper than 87.63% of the companies listed in the same industry.
  • The average S&P500 Price/Forward Earnings ratio is at 25.64. PHG is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 16.62
Fwd PE 16.15
PHG Price Earnings VS Forward Price EarningsPHG Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, PHG is valued cheaply inside the industry as 85.48% of the companies are valued more expensively.
  • Based on the Price/Free Cash Flow ratio, PHG is valued a bit cheaper than the industry average as 75.27% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 40.93
EV/EBITDA 12.89
PHG Per share dataPHG EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates PHG does not grow enough to justify the current Price/Earnings ratio.
PEG (NY)3.36
PEG (5Y)N/A
EPS Next 2Y4.81%
EPS Next 3Y7.44%

More info and screens

5

5. Dividend

5.1 Amount

  • PHG has a Yearly Dividend Yield of 4.02%, which is a nice return.
  • Compared to an average industry Dividend Yield of 0.21, PHG pays a better dividend. On top of this PHG pays more dividend than 98.92% of the companies listed in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.83, PHG pays a better dividend.
Industry RankSector Rank
Dividend Yield 4.02%

5.2 History

  • The dividend of PHG decreases each year by -70.49%.
  • PHG has been paying a dividend for at least 10 years, so it has a reliable track record.
Dividend Growth(5Y)-70.49%
Div Incr Years0
Div Non Decr Years0
PHG Yearly Dividends per sharePHG Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2025 0.5 1 1.5

5.3 Sustainability

  • PHG pays out 199.39% of its income as dividend. This is not a sustainable payout ratio.
DP199.39%
EPS Next 2Y4.81%
EPS Next 3Y7.44%
PHG Yearly Income VS Free CF VS DividendPHG Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B 2B 3B 4B
PHG Dividend Payout.PHG Dividend Payout, showing the Payout Ratio.PHG Dividend Payout.PayoutRetained Earnings

More info and screens

KONINKLIJKE PHILIPS NVR- NY

NYSE:PHG (2/3/2026, 10:54:05 AM)

29.09

+0.19 (+0.66%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-04
Earnings (Next)02-10
Inst Owners44.83%
Inst Owner Change-0.32%
Ins Owners0.06%
Ins Owner ChangeN/A
Market Cap28.01B
Revenue(TTM)17.78B
Net Income(TTM)165.00M
Analysts72.14
Price Target31.61 (8.66%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 4.02%
Yearly Dividend0
Dividend Growth(5Y)-70.49%
DP199.39%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)22.57%
Min EPS beat(2)14.1%
Max EPS beat(2)31.04%
EPS beat(4)3
Avg EPS beat(4)13.85%
Min EPS beat(4)-11.97%
Max EPS beat(4)31.04%
EPS beat(8)3
Avg EPS beat(8)-0.89%
EPS beat(12)6
Avg EPS beat(12)18.79%
EPS beat(16)6
Avg EPS beat(16)4.51%
Revenue beat(2)0
Avg Revenue beat(2)-2.19%
Min Revenue beat(2)-2.4%
Max Revenue beat(2)-1.97%
Revenue beat(4)0
Avg Revenue beat(4)-2.34%
Min Revenue beat(4)-3.04%
Max Revenue beat(4)-1.96%
Revenue beat(8)0
Avg Revenue beat(8)-3.43%
Revenue beat(12)2
Avg Revenue beat(12)-1.64%
Revenue beat(16)2
Avg Revenue beat(16)-1.76%
PT rev (1m)-1.82%
PT rev (3m)-1.25%
EPS NQ rev (1m)1.37%
EPS NQ rev (3m)5.07%
EPS NY rev (1m)0.57%
EPS NY rev (3m)4.51%
Revenue NQ rev (1m)-0.52%
Revenue NQ rev (3m)-0.62%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.45%
Valuation
Industry RankSector Rank
PE 16.62
Fwd PE 16.15
P/S 1.33
P/FCF 40.93
P/OCF 19.28
P/B 2.24
P/tB N/A
EV/EBITDA 12.89
EPS(TTM)1.75
EY6.02%
EPS(NY)1.8
Fwd EY6.19%
FCF(TTM)0.71
FCFY2.44%
OCF(TTM)1.51
OCFY5.19%
SpS21.86
BVpS12.97
TBVpS-1.68
PEG (NY)3.36
PEG (5Y)N/A
Graham Number22.6
Profitability
Industry RankSector Rank
ROA 0.63%
ROE 1.56%
ROCE 5.61%
ROIC 4.44%
ROICexc 4.44%
ROICexgc 11.59%
OM 6.1%
PM (TTM) 0.93%
GM 43.49%
FCFM 3.25%
ROA(3y)-3.08%
ROA(5y)1.15%
ROE(3y)-7.29%
ROE(5y)2.23%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y10.6%
ROICexgc growth 5Y-2.51%
ROICexc growth 3Y4.73%
ROICexc growth 5Y-6.98%
OM growth 3Y-1.59%
OM growth 5Y-8.09%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.71%
GM growth 5Y1.08%
F-ScoreN/A
Asset Turnover0.68
Health
Industry RankSector Rank
Debt/Equity 0.69
Debt/FCF 14.51
Debt/EBITDA 2.93
Cap/Depr 46.69%
Cap/Sales 3.65%
Interest Coverage 250
Cash Conversion 49.6%
Profit Quality 350.3%
Current Ratio 1.32
Quick Ratio 0.86
Altman-Z 1.98
F-ScoreN/A
WACC6.8%
ROIC/WACC0.65
Cap/Depr(3y)50.01%
Cap/Depr(5y)53.78%
Cap/Sales(3y)3.94%
Cap/Sales(5y)4.29%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)15.15%
EPS 3Y-5.66%
EPS 5Y-7.17%
EPS Q2Q%12.5%
EPS Next Y4.94%
EPS Next 2Y4.81%
EPS Next 3Y7.44%
EPS Next 5Y10.28%
Revenue 1Y (TTM)-1.43%
Revenue growth 3Y1.65%
Revenue growth 5Y1%
Sales Q2Q%-1.71%
Revenue Next Year-2.27%
Revenue Next 2Y0.25%
Revenue Next 3Y1.58%
Revenue Next 5Y3%
EBIT growth 1Y712.43%
EBIT growth 3Y0.03%
EBIT growth 5Y-7.17%
EBIT Next Year48.95%
EBIT Next 3Y19.49%
EBIT Next 5Y15.13%
FCF growth 1Y-45.51%
FCF growth 3Y-40.93%
FCF growth 5Y-1.73%
OCF growth 1Y-31.12%
OCF growth 3Y-32.38%
OCF growth 5Y-4.03%

KONINKLIJKE PHILIPS NVR- NY / PHG FAQ

What is the ChartMill fundamental rating of KONINKLIJKE PHILIPS NVR- NY (PHG) stock?

ChartMill assigns a fundamental rating of 4 / 10 to PHG.


Can you provide the valuation status for KONINKLIJKE PHILIPS NVR- NY?

ChartMill assigns a valuation rating of 5 / 10 to KONINKLIJKE PHILIPS NVR- NY (PHG). This can be considered as Fairly Valued.


How profitable is KONINKLIJKE PHILIPS NVR- NY (PHG) stock?

KONINKLIJKE PHILIPS NVR- NY (PHG) has a profitability rating of 4 / 10.


How financially healthy is KONINKLIJKE PHILIPS NVR- NY?

The financial health rating of KONINKLIJKE PHILIPS NVR- NY (PHG) is 3 / 10.


Is the dividend of KONINKLIJKE PHILIPS NVR- NY sustainable?

The dividend rating of KONINKLIJKE PHILIPS NVR- NY (PHG) is 5 / 10 and the dividend payout ratio is 199.39%.